Sanara MedTech (SMTI) Long-Term Investments (2018 - 2026)

Sanara MedTech's Long-Term Investments history runs 8 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• Quarterly Long-Term Investments rose 32.5% year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (up 32.5% YoY) and the FY2025 annual result came in at $14.6 million, up 135.43% from the prior year.
• Long-Term Investments was $14.2 million for Q1 2026 at Sanara MedTech, down from $14.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $14.6 million in Q4 2025 and bottomed at $3.1 million in Q2 2022.
• A 5-year average of $6.5 million and a median of $3.1 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments slumped 38.53% — and 2025, when it surged 246.61%.
• Sanara MedTech's Long-Term Investments stood at $3.1 million in 2022, then changed by 0.0% to $3.1 million in 2023, then soared by 101.44% to $6.2 million in 2024, then surged by 135.43% to $14.6 million in 2025, then slipped by 3.16% to $14.2 million in 2026.
• Business Quant data shows SMTI's Long-Term Investments at $14.2 million in Q1 2026, $14.6 million in Q4 2025, and $12.6 million in Q3 2025.